Get 20% lifetime commission for referring investors to digrin.com
here.
Innate Pharma S.A. ( IPHA) - Key Metrics
IPHA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.03 | -$0.21 | -$0.23 | -$0.23 |
| 2025Q4 | -$0.02 | -$0.30 | -$0.26 | -$0.26 |
| 2025Q2 | $0.06 | -$0.25 | -$0.40 | -$0.40 |
| 2024Q4 | $0 | -$0.30 | -$0.12 | -$0.12 |
| 2024Q2 | $0.15 | -$0.31 | $0.04 | $0.03 |
IPHA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.92 |
| 2025Q4 | 0% | -1.24 |
| 2025Q2 | 0% | -1.54 |
| 2024Q4 | 0% | -1.48 |
| 2024Q2 | 0% | -1.56 |
IPHA
Price: $1.43
52 week price:
Earnings Per Share: -0.59 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 6529
Market Capitalization: 149.3 million